ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
22.328,77
-1,23%
S&P 500
5.572,07
-0,76%
Dow Jones
41.433,48
-1,14%
Euro vs US Dollar
1,09166
0,72%
Bitcoin
82.694,97
5,38%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. IceCure Medical Ltd (ICCM)

  7. IceCure Medical Ltd (ICCM) News

ICCM

IceCure Medical (ICCM)

IceCure Medical Ltd
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ICCM
DatumZeitQuelleÜberschriftSymbolFirma
10/03/202513h35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICCMIceCure Medical Ltd
10/03/202513h30PR Newswire (US)Breast Cancer Patients who Underwent IceCure's ProSense® Cryoablation in Japan Reported Significantly Higher Satisfaction than Patients who Underwent Standard of Care SurgeryNASDAQ:ICCMIceCure Medical Ltd
24/02/202514h40Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICCMIceCure Medical Ltd
24/02/202514h30PR Newswire (US)IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense™ Cryoablation System in IsraelNASDAQ:ICCMIceCure Medical Ltd
04/02/202514h35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICCMIceCure Medical Ltd
04/02/202514h30PR Newswire (US)IceCure's ProSense® in the Spotlight at Society of Interventional Oncology (SIO) Annual Meeting: Award Winning Abstract and Hands-On Training for Breast Cryoablation as Medical Community Anticipates FDA's Market Authorization DecisionNASDAQ:ICCMIceCure Medical Ltd
27/01/202514h40Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICCMIceCure Medical Ltd
27/01/202514h30PR Newswire (US)IceCure Files for Regulatory Approval of ProSense® Cryoablation System in ChinaNASDAQ:ICCMIceCure Medical Ltd
13/01/202514h21Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ICCMIceCure Medical Ltd
13/01/202513h59Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICCMIceCure Medical Ltd
13/01/202513h16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICCMIceCure Medical Ltd
13/01/202513h00PR Newswire (US)IceCure Medical CEO Issues Letter to Shareholders & Reports Increase of 42% in ProSense® Sales for 2024 in North AmericaNASDAQ:ICCMIceCure Medical Ltd
06/01/202514h40Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICCMIceCure Medical Ltd
06/01/202514h30PR Newswire (US)IceCure Medical Regains Full Nasdaq Compliance with Nasdaq Minimum Closing Bid Price RuleNASDAQ:ICCMIceCure Medical Ltd
03/01/202514h35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICCMIceCure Medical Ltd
03/01/202514h30PR Newswire (US)European Patent Office Issues Intention to Grant Notice to IceCure for its Next-Generation Cryoablation TechnologyNASDAQ:ICCMIceCure Medical Ltd
30/12/202414h42Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICCMIceCure Medical Ltd
16/12/202414h30PR Newswire (US)Data on IceCure's ProSense® Cryoablation for Low-Risk Breast Cancer Presented at Radiological Society of North America's 2024 Annual MeetingNASDAQ:ICCMIceCure Medical Ltd
05/12/202414h35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICCMIceCure Medical Ltd
05/12/202414h30PR Newswire (US)IceCure's ProSense® Cryoablation Safe and Effective in Destruction of Kidney Tumors with 88.7% Recurrence-Free Rate Based on Interim ICESECRET Study ResultsNASDAQ:ICCMIceCure Medical Ltd
26/11/202414h35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICCMIceCure Medical Ltd
26/11/202414h30PR Newswire (US)IceCure Medical Reports 36% Sales Growth in the First Nine Months of 2024 Driven by Global Adoption of ProSense® CryoablationNASDAQ:ICCMIceCure Medical Ltd
25/11/202414h50Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICCMIceCure Medical Ltd
25/11/202414h30PR Newswire (US)IceCure's Next-Generation Multiprobe Cryoablation Technology Issued Notice of Allowance from Japan's Patent OfficeNASDAQ:ICCMIceCure Medical Ltd
20/11/202414h30PR Newswire (US)IceCure Medical to Report Third Quarter 2024 Financial & Operational Results on November 26, 2024NASDAQ:ICCMIceCure Medical Ltd
19/11/202414h30PR Newswire (US)IceCure's ProSense® Chosen for Breast Cryoablation Study Led by the Prestigious European Institute of Oncology with Sponsorship from the Italian Ministry of HealthNASDAQ:ICCMIceCure Medical Ltd
15/11/202403h38Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ICCMIceCure Medical Ltd
08/11/202416h05Edgar (US Regulatory)Form F-1/A - Registration statement for certain foreign private issuers: [Amend]NASDAQ:ICCMIceCure Medical Ltd
08/11/202413h08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ICCMIceCure Medical Ltd
08/11/202413h00PR Newswire (US)FDA Advisory Panel Votes in Favor of IceCure's ProSense® Cryoablation Benefit-Risk Profile in Early-Stage Low Risk Breast CancerNASDAQ:ICCMIceCure Medical Ltd
 Showing the most relevant articles for your search:NASDAQ:ICCM

Kürzlich von Ihnen besucht

NASDAQ
NVDA
NVIDIA
AMEX
XLF
Financial Select Sector
NYSE
KO
Coca Cola
USOTC
DTEGY
Deutsche Telekom (QX)
TG
NOV
Novo Nordisk
NYSE
MRK
Merck
USOTC
RHHBY
Roche (QX)
TG
ALV
Allianz
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
AAPL
Apple
NASDAQ
AMZN
Amazon.com
USOTC
ADDYY
Adidas (QX)
TG
RHM
Rheinmetall
TG
BAS
BASF
COIN
SOLUSD
Solana
NYSE
NKE
Nike
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten